Site icon FintekAsia

Shenzhen Capital Group Co-Leads $62M Round In Chinese Biopharmaceutical Firm Zelgen

...biopharmaceutical company. Northern Light Venture Capital and China Youth Finance Network also participated in the round, according to a company announcement. Founded in 2009, Zelgen specialzes in the development, production...

Shenzhen Capital Group Co-Leads $62M Round In Chinese Biopharmaceutical Firm Zelgen appeared first on China Money Network.

Exit mobile version